» Articles » PMID: 1528870

A Major Binding Protein for Leukemia Inhibitory Factor in Normal Mouse Serum: Identification As a Soluble Form of the Cellular Receptor

Overview
Specialty Science
Date 1992 Sep 15
PMID 1528870
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

A protein that specifically binds leukemia inhibitory factor (LIF) has been isolated from normal mouse serum by using four successive fractionation steps: chromatography on a LIF affinity matrix, anion-exchange chromatography, size-exclusion chromatography, and preparative native gel electrophoresis. The purified LIF-binding protein (LBP) is a glycoprotein with an apparent molecular mass of 90 kDa that specifically binds 125I-labeled murine LIF with an affinity comparable to that of the low-affinity cellular LIF receptor (Kd = 600 pM). N-terminal sequencing has identified this protein as a soluble truncated form of the alpha chain of the cellular LIF receptor. LBP is present in normal mouse serum at high levels (1 microgram/ml) and these levels are elevated in pregnant mice and reduced in neonatal mice. Since normal serum concentrations of LBP can block the biological actions of LIF in culture, LBP may serve as an inhibitor of the systemic effects of locally produced LIF.

Citing Articles

Oncostatin M: Dual Regulator of the Skeletal and Hematopoietic Systems.

Sims N, Levesque J Curr Osteoporos Rep. 2024; 22(1):80-95.

PMID: 38198032 PMC: 10912291. DOI: 10.1007/s11914-023-00837-z.


Leukemia Inhibitory Factor: An Important Cytokine in Pathologies and Cancer.

Jorgensen M, de la Puente P Biomolecules. 2022; 12(2).

PMID: 35204717 PMC: 8961628. DOI: 10.3390/biom12020217.


Loss of reduces the efficiency of embryonic stem cell self-renewal and germline entry.

Vojtek M, Chambers I Life Sci Alliance. 2021; 4(12).

PMID: 34607919 PMC: 8500223. DOI: 10.26508/lsa.202101190.


An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy.

Hunter S, McIntosh B, Shi Y, Parra Sperberg R, Funatogawa C, Labanieh L Commun Biol. 2021; 4(1):452.

PMID: 33846527 PMC: 8041770. DOI: 10.1038/s42003-021-01928-2.


Historical overview of the interleukin-6 family cytokine.

Kang S, Narazaki M, Metwally H, Kishimoto T J Exp Med. 2020; 217(5).

PMID: 32267936 PMC: 7201933. DOI: 10.1084/jem.20190347.


References
1.
Metcalf D, Hilton D, Nicola N . Clonal analysis of the actions of the murine leukemia inhibitory factor on leukemic and normal murine hemopoietic cells. Leukemia. 1988; 2(4):216-21. View

2.
Mosley B, Beckmann M, March C, Idzerda R, Gimpel S, Vandenbos T . The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell. 1989; 59(2):335-48. DOI: 10.1016/0092-8674(89)90295-x. View

3.
Hilton D, Nicola N, Metcalf D . Specific binding of murine leukemia inhibitory factor to normal and leukemic monocytic cells. Proc Natl Acad Sci U S A. 1988; 85(16):5971-5. PMC: 281887. DOI: 10.1073/pnas.85.16.5971. View

4.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

5.
Nicola N, Cary D . Affinity conversion of receptors for colony stimulating factors: properties of solubilized receptors. Growth Factors. 1992; 6(2):119-29. DOI: 10.3109/08977199209011015. View